US Stock MarketDetailed Quotes

GUTS Fractyl Health

Watchlist
  • 5.360
  • -0.020-0.37%
Close Jun 20 16:00 ET
  • 5.380
  • +0.020+0.37%
Post 19:37 ET
256.73MMarket Cap2.44P/E (TTM)

Fractyl Health Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.63%-11.71M
7.40%-42.82M
15.43%-10.6M
-13.32%-11.02M
-11.66M
-9.55M
-38.20%-46.24M
-12.53M
-4.12%-9.72M
-7.69%-33.46M
Net income from continuing operations
72.16%-3.32M
-65.95%-77.09M
-76.64%-19.18M
-42.33%-15.75M
---30.23M
---11.93M
-19.93%-46.45M
---10.86M
-21.18%-11.06M
-27.08%-38.74M
Operating gains losses
-209,000.00%-10.45M
3,738.42%6.79M
37,653.33%5.63M
10,170.00%1.03M
--129K
--5K
-51.37%177K
---15K
233.33%10K
2,326.67%364K
Depreciation and amortization
-33.75%53K
-36.73%286K
-53.09%38K
3.70%84K
--84K
--80K
-33.14%452K
--81K
-49.38%81K
-12.21%676K
Other non cash items
-1,502.96%-6.64M
1,046.13%21.9M
440.77%443K
1,418.98%2.85M
--18.14M
--473K
-637.12%-2.32M
---130K
-325.00%-216K
-14.14%431K
Change In working capital
253.88%3.42M
179.63%989K
147.30%1.19M
-145.79%-321K
---848K
--967K
-172.59%-1.24M
---2.52M
164.43%701K
148.80%1.71M
-Change in receivables
240.00%7K
---22K
--2K
--32K
---51K
---5K
--0
--0
--0
----
-Change in inventory
--0
---73K
--3K
---3K
--0
---73K
--0
--0
--0
----
-Change in prepaid assets
-184.25%-599K
122.91%331K
89.65%-133K
-1,151.72%-305K
--58K
--711K
-268.02%-1.45M
---1.29M
-72.64%29K
209.00%860K
-Change in payables and accrued expense
350.61%3.35M
112.62%116K
150.57%444K
-99.25%8K
---1.08M
--743K
-124.42%-919K
---878K
235.11%1.06M
1,113.87%3.76M
-Change in other current liabilities
369.82%599K
----
----
----
----
---222K
----
----
----
----
-Change in other working capital
135.83%67K
-43.23%637K
346.48%875K
86.41%-53K
--2K
---187K
138.53%1.12M
---355K
4.41%-390K
3.80%-2.91M
Cash from discontinued investing activities
Operating cash flow
-22.63%-11.71M
7.40%-42.82M
15.43%-10.6M
-13.32%-11.02M
---11.66M
---9.55M
-38.20%-46.24M
---12.53M
-4.12%-9.72M
-7.69%-33.46M
Investing cash flow
Cash flow from continuing investing activities
-5,195.00%-1.06M
-541.07%-359K
-136K
-184.62%-148K
-55K
-20K
-9.80%-56K
0
-52K
-2,450.00%-51K
Net PPE purchase and sale
-5,195.00%-1.06M
-541.07%-359K
---136K
-184.62%-148K
---55K
---20K
-9.80%-56K
--0
---52K
-2,450.00%-51K
Cash from discontinued investing activities
Investing cash flow
-5,195.00%-1.06M
-541.07%-359K
---136K
-184.62%-148K
---55K
---20K
-9.80%-56K
--0
---52K
-2,450.00%-51K
Financing cash flow
Cash flow from continuing financing activities
5,050,200.00%101M
530.74%27.44M
-18,433.33%-556K
87,296.88%27.97M
28K
-2K
-95.64%4.35M
-3K
-99.76%32K
83.63%99.88M
Net issuance payments of debt
0.00%-2K
603.60%28.35M
0.00%-3K
1,417,850.00%28.36M
---2K
---2K
57,657.14%4.03M
---3K
0.00%-2K
0.00%-7K
Net common stock issuance
--103.7M
----
----
----
----
--0
----
----
----
----
Net preferred stock issuance
----
----
----
----
----
----
----
----
----
83.63%99.85M
Proceeds from stock option exercised by employees
--163K
-83.80%52K
--17K
-85.29%5K
--30K
--0
702.50%321K
--0
3,300.00%34K
66.67%40K
Net other financing activities
---2.85M
---963K
---570K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
5,050,200.00%101M
530.74%27.44M
-18,433.33%-556K
87,296.88%27.97M
--28K
---2K
-95.64%4.35M
---3K
-99.76%32K
83.63%99.88M
Net cash flow
Beginning cash position
-29.42%37.78M
-43.94%53.52M
-25.72%49.07M
-57.43%32.27M
--43.95M
--53.52M
228.01%95.47M
--66.06M
-25.17%75.8M
402.54%29.11M
Current changes in cash
1,021.77%88.23M
62.47%-15.75M
9.93%-11.29M
272.44%16.8M
---11.68M
---9.57M
-163.21%-41.95M
---12.54M
-339.92%-9.74M
184.65%66.37M
End cash Position
186.70%126.01M
-29.42%37.78M
-29.42%37.78M
-25.72%49.07M
--32.27M
--43.95M
-43.94%53.52M
--53.52M
-37.30%66.06M
228.01%95.47M
Free cash flow
-33.44%-12.77M
6.73%-43.18M
14.35%-10.74M
-14.23%-11.17M
---11.71M
---9.57M
-38.15%-46.3M
---12.53M
-4.68%-9.78M
-7.85%-33.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.63%-11.71M7.40%-42.82M15.43%-10.6M-13.32%-11.02M-11.66M-9.55M-38.20%-46.24M-12.53M-4.12%-9.72M-7.69%-33.46M
Net income from continuing operations 72.16%-3.32M-65.95%-77.09M-76.64%-19.18M-42.33%-15.75M---30.23M---11.93M-19.93%-46.45M---10.86M-21.18%-11.06M-27.08%-38.74M
Operating gains losses -209,000.00%-10.45M3,738.42%6.79M37,653.33%5.63M10,170.00%1.03M--129K--5K-51.37%177K---15K233.33%10K2,326.67%364K
Depreciation and amortization -33.75%53K-36.73%286K-53.09%38K3.70%84K--84K--80K-33.14%452K--81K-49.38%81K-12.21%676K
Other non cash items -1,502.96%-6.64M1,046.13%21.9M440.77%443K1,418.98%2.85M--18.14M--473K-637.12%-2.32M---130K-325.00%-216K-14.14%431K
Change In working capital 253.88%3.42M179.63%989K147.30%1.19M-145.79%-321K---848K--967K-172.59%-1.24M---2.52M164.43%701K148.80%1.71M
-Change in receivables 240.00%7K---22K--2K--32K---51K---5K--0--0--0----
-Change in inventory --0---73K--3K---3K--0---73K--0--0--0----
-Change in prepaid assets -184.25%-599K122.91%331K89.65%-133K-1,151.72%-305K--58K--711K-268.02%-1.45M---1.29M-72.64%29K209.00%860K
-Change in payables and accrued expense 350.61%3.35M112.62%116K150.57%444K-99.25%8K---1.08M--743K-124.42%-919K---878K235.11%1.06M1,113.87%3.76M
-Change in other current liabilities 369.82%599K-------------------222K----------------
-Change in other working capital 135.83%67K-43.23%637K346.48%875K86.41%-53K--2K---187K138.53%1.12M---355K4.41%-390K3.80%-2.91M
Cash from discontinued investing activities
Operating cash flow -22.63%-11.71M7.40%-42.82M15.43%-10.6M-13.32%-11.02M---11.66M---9.55M-38.20%-46.24M---12.53M-4.12%-9.72M-7.69%-33.46M
Investing cash flow
Cash flow from continuing investing activities -5,195.00%-1.06M-541.07%-359K-136K-184.62%-148K-55K-20K-9.80%-56K0-52K-2,450.00%-51K
Net PPE purchase and sale -5,195.00%-1.06M-541.07%-359K---136K-184.62%-148K---55K---20K-9.80%-56K--0---52K-2,450.00%-51K
Cash from discontinued investing activities
Investing cash flow -5,195.00%-1.06M-541.07%-359K---136K-184.62%-148K---55K---20K-9.80%-56K--0---52K-2,450.00%-51K
Financing cash flow
Cash flow from continuing financing activities 5,050,200.00%101M530.74%27.44M-18,433.33%-556K87,296.88%27.97M28K-2K-95.64%4.35M-3K-99.76%32K83.63%99.88M
Net issuance payments of debt 0.00%-2K603.60%28.35M0.00%-3K1,417,850.00%28.36M---2K---2K57,657.14%4.03M---3K0.00%-2K0.00%-7K
Net common stock issuance --103.7M------------------0----------------
Net preferred stock issuance ------------------------------------83.63%99.85M
Proceeds from stock option exercised by employees --163K-83.80%52K--17K-85.29%5K--30K--0702.50%321K--03,300.00%34K66.67%40K
Net other financing activities ---2.85M---963K---570K----------------------------
Cash from discontinued financing activities
Financing cash flow 5,050,200.00%101M530.74%27.44M-18,433.33%-556K87,296.88%27.97M--28K---2K-95.64%4.35M---3K-99.76%32K83.63%99.88M
Net cash flow
Beginning cash position -29.42%37.78M-43.94%53.52M-25.72%49.07M-57.43%32.27M--43.95M--53.52M228.01%95.47M--66.06M-25.17%75.8M402.54%29.11M
Current changes in cash 1,021.77%88.23M62.47%-15.75M9.93%-11.29M272.44%16.8M---11.68M---9.57M-163.21%-41.95M---12.54M-339.92%-9.74M184.65%66.37M
End cash Position 186.70%126.01M-29.42%37.78M-29.42%37.78M-25.72%49.07M--32.27M--43.95M-43.94%53.52M--53.52M-37.30%66.06M228.01%95.47M
Free cash flow -33.44%-12.77M6.73%-43.18M14.35%-10.74M-14.23%-11.17M---11.71M---9.57M-38.15%-46.3M---12.53M-4.68%-9.78M-7.85%-33.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg